Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Niche01:26

Stem Cell Niche

5.4K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.4K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of human airway-derived decellularized extracellulr matrix hydrogels and their effects on airway epithelial cell growth, organization and differentiation.

Biomaterials·2026
Same author

Recreating the Native Airway Microenvironment Using Tissue-Specific Extracellular Matrix Bioinks for Proximal Airway Engineering.

bioRxiv : the preprint server for biology·2026
Same author

20 years of Progress in Stem Cells, Cell Therapy, and Bioengineering in Lung Biology and Diseases.

American journal of respiratory cell and molecular biology·2026
Same author

Progenitor Resilience and the Early Onset of Chronic Lung Diseases: NHLBI workshop report.

American journal of respiratory cell and molecular biology·2026
Same author

Proinflammatory Cytokine Preconditioning Enhances the Therapeutic Potency of Different Types of MSCs in Inflammation.

International journal of molecular sciences·2026
Same author

Polarization of Bone Marrow-Derived Macrophages from Wild-Type and High Human MIF-Expressing CATT<sub>7</sub> Polymorphic Mice.

Methods in molecular biology (Clifton, N.J.)·2026

Related Experiment Video

Updated: Oct 12, 2025

Isolation of CD146+ Resident Lung Mesenchymal Stromal Cells from Rat Lungs
09:47

Isolation of CD146+ Resident Lung Mesenchymal Stromal Cells from Rat Lungs

Published on: June 17, 2016

8.5K

The Inflammatory Lung Microenvironment; a Key Mediator in MSC Licensing.

Hazel Dunbar1,2, Daniel J Weiss3, Sara Rolandsson Enes4

  • 1Department of Biology, Maynooth University, W23 F2H6 Maynooth, Ireland.

Cells
|November 27, 2021
PubMed
Summary

Mesenchymal stromal cell (MSC) therapy shows promise for inflammatory conditions like ARDS. However, patient responses vary due to the disease microenvironment influencing MSC function, necessitating a personalized approach.

Keywords:
MSCcytokinesimmunomodulatoryinflammatorylicensinglungmicroenvironment

More Related Videos

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging
09:10

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging

Published on: July 16, 2021

3.4K
Isolation & Characterization of Hoechstlow CD45negative Mouse Lung Mesenchymal Stem Cells
16:55

Isolation & Characterization of Hoechstlow CD45negative Mouse Lung Mesenchymal Stem Cells

Published on: October 26, 2011

20.6K

Related Experiment Videos

Last Updated: Oct 12, 2025

Isolation of CD146+ Resident Lung Mesenchymal Stromal Cells from Rat Lungs
09:47

Isolation of CD146+ Resident Lung Mesenchymal Stromal Cells from Rat Lungs

Published on: June 17, 2016

8.5K
Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging
09:10

Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging

Published on: July 16, 2021

3.4K
Isolation & Characterization of Hoechstlow CD45negative Mouse Lung Mesenchymal Stem Cells
16:55

Isolation & Characterization of Hoechstlow CD45negative Mouse Lung Mesenchymal Stem Cells

Published on: October 26, 2011

20.6K

Area of Science:

  • Immunology
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Mesenchymal stromal cells (MSCs) offer therapeutic benefits for inflammatory diseases.
  • Acute Respiratory Distress Syndrome (ARDS) is a critical inflammatory lung condition with potential for MSC therapy.
  • Patient response to MSC therapy is inconsistent, suggesting influencing factors.

Purpose of the Study:

  • To investigate the role of the disease microenvironment in modulating MSC function.
  • To highlight the importance of MSC licensing and activation in therapeutic efficacy.
  • To advocate for a patient-stratification approach in MSC therapy for ARDS.

Main Methods:

  • Review of recent clinical trial data on MSC therapy for inflammatory conditions.
  • Analysis of factors influencing MSC licensing and function within disease microenvironments.
  • Discussion of patient stratification strategies for optimizing MSC therapy.

Main Results:

  • MSC therapy demonstrates significant benefits in responsive patients with inflammatory conditions.
  • The disease microenvironment critically influences MSC licensing, activation, and therapeutic outcomes.
  • Variability in patient responses is linked to differences in disease microenvironments and severity.

Conclusions:

  • Understanding the disease microenvironment's impact on MSCs is crucial for improving ARDS treatment.
  • MSC licensing and activation are key determinants of therapeutic success.
  • A patient-stratification approach is essential for tailoring MSC therapy and maximizing efficacy in ARDS.